in response to the intravenous injection of flecainide , atrial fibrillation ( 90 % ) , atrial tachycardia ( 100 % ) , intra-av nodal tachycardia ( 89 % ) and atrioventricular re-entrant tachycardia ( 80 % ) are generally terminated , and although atrial flutter is slowed , only a small proportion ( 20 % ) is terminated .
C0016229
flecainide
C0004238
atrial fibrillation